GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
H

Harrow HROW · USD

Health Care · US listing · 🇺🇸 United States

Compare

27.47

+2.16%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Harrow

From its filings with the US Securities and Exchange Commission

SEC filings

Harrow is based in Nashville, Tennessee and is incorporated in Delaware. Its shares trade on Nasdaq under the ticker HROW. The SEC classifies its business as pharmaceutical preparations. In the fiscal year to 31 December 2025, it reported revenue of $272.3m and a net loss of $5.1m. At that date it held total assets of $399.5m and shareholders' equity of $52.4m.

Read the filing on SEC.gov ↗

Company facts

Sector
Health Care
Industry
Pharmaceuticals
Listed since
8 Feb 2013
Employees
373
Head office
1A BURTON HILLS BLVD, NASHVILLE, TN
Incorporated in
DE
Classification
Pharmaceutical Preparations
Filer status
Large accelerated filer

Leadership

Pay as last reported

  • Mr. Mark BaumChairman of the Board, Chief Executive Officer, since 2011$1.4m
  • Mr. Andrew BollPresident, Chief Financial Officer, Company Secretary$849,201
  • Mr. Frank MulleryChief Executive Officer of ImprimisRx
  • Mr. Randall PollardChief Accounting Officer
  • Mr. Amir ShojaeiChief Scientific Officer
  • Mr. Patrick SullivanChief Commercial Officer
  • Mr. Perry SternbergLead Independent Director$252,500
  • Dr. Adrienne GravesIndependent Director$260,285
  • Mrs. Lauren SilvernailIndependent Director$257,785

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
28
Environment
11
Social
39
Governance
34
Direct emissions (scope 1)
89,648 t
Energy emissions (scope 2)
39,470 t
Carbon reduction policy
No
Human rights policy
No

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Harrow Health Inc possesses several strengths, which contribute to its competitive advantage in the market. These strengths include:

Weaknesses

  • Although Harrow Health Inc has demonstrated strengths, it also faces certain weaknesses, which need to be addressed for sustained growth. These weaknesses include:

Opportunities

  • Harrow Health Inc can capitalize on various opportunities to expand its market presence and enhance profitability. These opportunities are:

Threats

  • Harrow Health Inc must also be aware of potential threats that could hinder its progress. These threats include:

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.